相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Emerging Nondopaminergic Medications for Parkinson's Disease: Focusing on A2A Receptor Antagonists and GLP1 Receptor Agonists
Pei Shang et al.
JOURNAL OF MOVEMENT DISORDERS (2021)
Methylxanthines and Neurodegenerative Diseases: An Update
Daniel Janitschke et al.
NUTRIENTS (2021)
Adenosine kinase: A key regulator of purinergic physiology
Detlev Boison et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Antibiotic drugs alter zebrafish behavior
Barbara Dutra Petersen et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY (2021)
The Promise of the Zebrafish Model for Parkinson's Disease: Today's Science and Tomorrow's Treatment
Khairiah Razali et al.
FRONTIERS IN GENETICS (2021)
Equilibrative nucleoside transporter 1 inhibition rescues energy dysfunction and pathology in a model of tauopathy
Ching-Pang Chang et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Disease Onset in Huntington's Disease: When Is the Conversion?
Mayke Oosterloo et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2021)
Age-related shift in LTD is dependent on neuronal adenosine A2Areceptors interplay with mGluR5 and NMDA receptors
Mariana Temido-Ferreira et al.
MOLECULAR PSYCHIATRY (2020)
Tryptophan alleviates neuroendocrine and behavioral responses to stress in zebrafish
Ana C. V. V. Giacomini et al.
BEHAVIOURAL BRAIN RESEARCH (2020)
Huntington's Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers
Klaudia Cybulska et al.
MOLECULES (2020)
Treatment of Tardive Dyskinesia
Hassaan H. Bashir et al.
NEUROLOGIC CLINICS (2020)
Late-onset Huntington's disease with 40-42 CAG expansion
Elisa Capiluppi et al.
NEUROLOGICAL SCIENCES (2020)
Cortical and Striatal Circuits in Huntington's Disease
Sonja Blumenstock et al.
FRONTIERS IN NEUROSCIENCE (2020)
Medical, Surgical, and Genetic Treatment of Huntington Disease
Christine M. Stahl et al.
NEUROLOGIC CLINICS (2020)
Influence of 3-nitropropionic acid on physiological and behavioral responses in zebrafish larvae and adults
Melissa Talita Wiprich et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY (2020)
Withdrawal Effects Following Methionine Exposure in Adult Zebrafish
Rodrigo Zanandrea et al.
MOLECULAR NEUROBIOLOGY (2020)
The effect of 3-nitropropionic acid on behavioral dysfunction, neuron loss and gliosis in the brain of adult male rats: The case of prefrontal cortex, hippocampus and the cerebellum
Abolfazl Torabi et al.
TOXICON (2020)
Pyriproxyfen Exposure Impairs Cognitive Parameters and Alters Cortisol Levels in Zebrafish
Darlan Gusso et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2020)
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
Sarah J. Tabrizi et al.
NATURE REVIEWS NEUROLOGY (2020)
Can adenosine A2A receptor antagonists modify motor behavior and dyskinesia in experimental models of Parkinson's disease?
Tomoyuki Kanda et al.
PARKINSONISM & RELATED DISORDERS (2020)
Istradefylline: adenosine A2A receptor antagonist to reduce OFF time in Parkinson's disease
D. M. Paton
DRUGS OF TODAY (2020)
Efficacy of istradefylline for gait disorders with freezing of gait in Parkinson's disease: A single-arm, open-label, prospective, multicenter study
Mutsumi Iijima et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Withdrawal effects following repeated ethanol exposure are prevented by N-acetylcysteine in zebrafish
Ricieri Mocelin et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Adenosine receptor expression in the adult zebrafish retina
Stephanie L. Grillo et al.
PURINERGIC SIGNALLING (2019)
Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington?s disease: a review of clinical trial data
Daniel O. Claassen et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Sertoli Cells Avert Neuroinflammation-Induced Cell Death and Improve Motor Function and Striatal Atrophy in Rat Model of Huntington Disease
Houssein Ahmadi et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2018)
Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease
Chia-Chia Lee et al.
MOLECULAR NEUROBIOLOGY (2018)
Molecular Pathogenesis in Huntington's Disease
S. N. Illarioshkin et al.
BIOCHEMISTRY-MOSCOW (2018)
Insights into the aquaporin 4 of zebrafish (Danio rerio) through evolutionary analysis, molecular modeling and structural dynamics
Hirak Jyoti Chakraborty et al.
GENE REPORTS (2018)
Selective A2A receptor antagonist SCH 58261 modulates striatal oxidative stress and alleviates toxicity induced by 3-Nitropropionic acid in male Wistar rats
Cristiani F. Bortolatto et al.
METABOLIC BRAIN DISEASE (2017)
Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration
Jocelyn Stockwell et al.
MOLECULES (2017)
Safety and Exploratory Efficacy at 36 Months in Open-HART, an Open-Label Extension Study of Pridopidine in Huntington's Disease
Andrew McGarry et al.
JOURNAL OF HUNTINGTONS DISEASE (2017)
Manganese(II) chloride alters behavioral and neurochemical parameters in larvae and adult zebrafish
Stefani Altenhofen et al.
AQUATIC TOXICOLOGY (2017)
Interaction between handling induced stress and anxiolytic effects of ethanol in zebrafish: A behavioral and neurochemical analysis
Steven Tran et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Equilibrative nucleoside transporter ENT1 as a biomarker of Huntington disease
Xavier Guitart et al.
NEUROBIOLOGY OF DISEASE (2016)
Purine nucleosides in neuroregeneration and neuroprotection
Filipa F. Ribeiro et al.
NEUROPHARMACOLOGY (2016)
Purinergic receptors as potential therapeutic targets in Alzheimer's disease
Lucas T. Woods et al.
NEUROPHARMACOLOGY (2016)
Function Over Form: Modeling Groups of Inherited Neurological Conditions in Zebrafish
Robert A. Kozol et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
The global prevalence of Huntington's disease: a systematic review and discussion
Sheharyar Sajjad Baig et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2016)
Adenosine A2A receptors are necessary and sufficient to trigger memory impairment in adult mice
N. Pagnussat et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Benzodiazepines alter nucleotide and nucleoside hydrolysis in zebrafish (Danio rerio) brain
Stefani Altenhofen et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
Purinergic signalling in neuroregeneration
Geoffrey Burnstock
NEURAL REGENERATION RESEARCH (2015)
Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models
Wei Li et al.
NEUROBIOLOGY OF DISEASE (2015)
Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's disease
Shiraz Tyebji et al.
NEUROBIOLOGY OF DISEASE (2015)
Modulation of adenosine signaling prevents scopolamine-induced cognitive impairment in zebrafish
Josiane Woutheres Bortolotto et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2015)
Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands
Francisco Ciruela et al.
NEUROPHARMACOLOGY (2015)
Role of Adenosine Signaling on Pentylenetetrazole-Induced Seizures in Zebrafish
Anna Maria Siebel et al.
ZEBRAFISH (2015)
Beneficial effect of rice bran extract against 3-nitropropionic acid induced experimental Huntington's disease in rats
Navneet Kaur et al.
TOXICOLOGY REPORTS (2015)
Ancestry of Basal Ganglia Circuits: New Evidence in Teleosts
Mario F. Wullimann
JOURNAL OF COMPARATIVE NEUROLOGY (2014)
Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease
Antonella Ferrante et al.
NEUROBIOLOGY OF DISEASE (2014)
Improvement of mitochondrial NAD+/FAD+-linked state-3 respiration by caffeine attenuates quinolinic acid induced motor impairment in rats: Implications in Huntington's disease
Jitendriya Mishra et al.
PHARMACOLOGICAL REPORTS (2014)
The need for transparency and good practices in the qPCR literature
Stephen A. Bustin et al.
NATURE METHODS (2013)
Increased 5-Methylcytosine and Decreased 5-Hydroxymethylcytosine Levels are Associated with Reduced Striatal A2AR Levels in Huntington's Disease
Izaskun Villar-Menendez et al.
NEUROMOLECULAR MEDICINE (2013)
Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex
Takako Kadowaki Horita et al.
PSYCHOPHARMACOLOGY (2013)
Adenosine and Seizure Termination: Endogenous Mechanisms
Detlev Boison
EPILEPSY CURRENTS (2013)
Early exposure to caffeine affects gene expression of adenosine receptors, DARPP-32 and BDNF without affecting sensibility and morphology of developing zebrafish (Danio rerio)
Katiucia Marques Capiotti et al.
NEUROTOXICOLOGY AND TERATOLOGY (2011)
Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: Effects on locomotor activity
Lyndsey E. Collins et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Adenosine-Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders
K. Fuxe et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
3-Nitropropionic Acid as a Tool to Study the Mechanisms Involved in Huntington's Disease: Past, Present and Future
Isaac Tunez et al.
MOLECULES (2010)
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
Stephen A. Bustin et al.
CLINICAL CHEMISTRY (2009)
Identification of zebrafish A2 adenosine receptors and expression in developing embryos
Boehmler A. Wendy et al.
GENE EXPRESSION PATTERNS (2009)
A one-trial inhibitory avoidance task to zebrafish: Rapid acquisition of an NMDA-dependent long-term memory
Martina Blank et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2009)
A critical role of the adenosine A2A receptor in extrastriatal neurons in modulating psychomotor activity as revealed by opposite phenotypes of striatum and forebrain A2A receptor knock-outs
Hai-Ying Shen et al.
JOURNAL OF NEUROSCIENCE (2008)
Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease mice
M. R. Domenici et al.
NEUROBIOLOGY OF DISEASE (2007)
Validation of zebrafish (Danio rerio) reference genes for quantitative real-time RT-PCR normalization
Rongying Tang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2007)
Animal models of Huntington's disease
Shilpa Ramaswamy et al.
ILAR JOURNAL (2007)
Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease
Alessia Tarditi et al.
NEUROBIOLOGY OF DISEASE (2006)
3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease
E Brouillet et al.
JOURNAL OF NEUROCHEMISTRY (2005)
cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant huntingtin with expanded polyglutamine residues
MC Chiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model
SY Chou et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage
JS Fink et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Adenosine A2A-dopamine D2 receptor-receptor heteromerization -: Qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer
M Canals et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease
EYW Chan et al.
HUMAN MOLECULAR GENETICS (2002)
Lessons from animal models of Huntington's disease
DC Rubinsztein
TRENDS IN GENETICS (2002)
Blockade of adenosine A, receptors in the posterior cingulate cortex facilitates memory in rats
GS Pereira et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Adenosine in the central nervous system: release mechanisms and extracellular concentrations
S Latini et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Drinks like a fish:: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects
R Gerlai et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
The pattern of neurodegeneration in Huntington's disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease
M Glass et al.
NEUROSCIENCE (2000)
分享论文
